Parametric Portfolio Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.26M | Sell |
94,062
-20,247
| -18% | -$701K | ﹤0.01% | 2131 |
|
|
2021
Q4 | $3.35M | Buy |
114,309
+17,391
| +18% | +$509K | ﹤0.01% | 2127 |
|
|
2021
Q3 | $2.47M | Buy |
96,918
+24,017
| +33% | +$612K | ﹤0.01% | 2319 |
|
|
2021
Q2 | $2.55M | Buy |
72,901
+29,402
| +68% | +$1.03M | ﹤0.01% | 2295 |
|
|
2021
Q1 | $1.77M | Sell |
43,499
-324
| -0.7% | -$13.2K | ﹤0.01% | 2865 |
|
|
2020
Q4 | $1.9M | Sell |
43,823
-2,465
| -5% | -$107K | ﹤0.01% | 2685 |
|
|
2020
Q3 | $2.55M | Sell |
46,288
-20,320
| -31% | -$1.12M | ﹤0.01% | 2355 |
|
|
2020
Q2 | $4.21M | Buy |
66,608
+19,133
| +40% | +$1.21M | ﹤0.01% | 1992 |
|
|
2020
Q1 | $2.43M | Sell |
47,475
-9,764
| -17% | -$499K | ﹤0.01% | 2253 |
|
|
2019
Q4 | $4.55M | Buy |
57,239
+16,294
| +40% | +$1.3M | ﹤0.01% | 2131 |
|
|
2019
Q3 | $1.99M | Sell |
40,945
-3,921
| -9% | -$190K | ﹤0.01% | 2638 |
|
|
2019
Q2 | $2.36M | Buy |
44,866
+34,541
| +335% | +$1.82M | ﹤0.01% | 2554 |
|
|
2019
Q1 | $547K | Buy |
10,325
+3,951
| +62% | +$209K | ﹤0.01% | 3289 |
|
|
2018
Q4 | $262K | Buy |
6,374
+1,077
| +20% | +$44.3K | ﹤0.01% | 3567 |
|
|
2018
Q3 | $201K | Sell |
5,297
-1,295
| -20% | -$49.1K | ﹤0.01% | 3761 |
|
|
2018
Q2 | $298K | Sell |
6,592
-21,521
| -77% | -$973K | ﹤0.01% | 3558 |
|
|
2018
Q1 | $1.36M | Sell |
28,113
-1,755
| -6% | -$84.8K | ﹤0.01% | 2845 |
|
|
2017
Q4 | $1.18M | Sell |
29,868
-6,059
| -17% | -$238K | ﹤0.01% | 2928 |
|
|
2017
Q3 | $1.12M | Buy |
35,927
+4,984
| +16% | +$155K | ﹤0.01% | 2969 |
|
|
2017
Q2 | $846K | Buy |
30,943
+284
| +0.9% | +$7.77K | ﹤0.01% | 3074 |
|
|
2017
Q1 | $1.13M | Buy |
+30,659
| New | +$1.13M | ﹤0.01% | 2804 |
|